SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000891020-97-000359
Filing Date
1997-03-17
Accepted
1997-03-17 00:00:00
Documents
13
Period of Report
1996-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 TARGETED GENETICS 10-K405 169625
2 AMENDED & RESTATED ARTICLES OF INCORPORATION EX-3.1 42743
3 AMENDED AND RESTATED BYLAWS EX-3.2 61761
4 EMPLYMNT AGRMNT BTWN REGISTRANT & ITS EXEC OFFICRS EX-10.2 34375
5 REVISED LICENSE AGREEMENT EFFECTIVE OCTOBER 1 '96 EX-10.20 37012
6 REVISED LICENSE AGREEMENT EFFECTIVE OCT. 1, 1996 EX-10.21 36677
7 2ND AMENDMENT TO OLIVE WAY BLDG LEASE DTD 6/12/96 EX-10.25 7378
8 OFFICE LEASE, DATED AS OF OCT. 7, 1996 EX-10.26 94011
9 1992 RESTATED STOCK OPTION PLAN EX-10.32 43185
10 STOCK OPTION PLAN FOR NONEMPLOYEE DIRECTORS EX-10.33 16162
11 COMPUTATION OF NET LOSS PER SHARE EX-11.1 1864
12 CONSENT OF ERNST & YOUNG LLP EX-23.1 707
13 FINANCIAL DATA SCHEDULE EX-27.1 2055
  Complete submission text file 0000891020-97-000359.txt   550447
Mailing Address 1100 OLIVE WAY STE 100 SEATTLE WA 98101
Business Address 1100 OLIVE WAY STE 100 SEATTLE WA 98101 2066237612
TARGETED GENETICS CORP /WA/ (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-23930 | Film No.: 97557909
SIC: 2836 Biological Products, (No Diagnostic Substances)